526 related articles for article (PubMed ID: 26216692)
1. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of retigabine/ezogabine as adjunctive therapy in adult Asian patients with drug-resistant partial-onset seizures: A randomized, placebo-controlled Phase III study.
Lim KS; Lotay N; White R; Kwan P
Epilepsy Behav; 2016 Aug; 61():224-230. PubMed ID: 27376872
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.
Brodie MJ; Lerche H; Gil-Nagel A; Elger C; Hall S; Shin P; Nohria V; Mansbach H;
Neurology; 2010 Nov; 75(20):1817-24. PubMed ID: 20944074
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
[TBL] [Abstract][Full Text] [Related]
5. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
Sachdeo R; Partiot A; Biton V; Rosenfeld WE; Nohria V; Tompson D; DeRossett S; Porter RJ
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.
Biton V; Gil-Nagel A; Brodie MJ; Derossett SE; Nohria V
Epilepsy Res; 2013 Nov; 107(1-2):138-45. PubMed ID: 24094693
[TBL] [Abstract][Full Text] [Related]
7. Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.
Porter RJ; Burdette DE; Gil-Nagel A; Hall ST; White R; Shaikh S; DeRossett SE
Epilepsy Res; 2012 Aug; 101(1-2):103-12. PubMed ID: 22512894
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
Tompson DJ; Crean CS; Reeve R; Berry NS
Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
[TBL] [Abstract][Full Text] [Related]
9. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures.
Porter RJ; Partiot A; Sachdeo R; Nohria V; Alves WM;
Neurology; 2007 Apr; 68(15):1197-204. PubMed ID: 17420403
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.
Gil-Nagel A; Brodie MJ; Leroy R; Cyr T; Hall S; Castiglia M; Twomey C; VanLandingham K
Epilepsy Res; 2012 Nov; 102(1-2):117-21. PubMed ID: 22771137
[TBL] [Abstract][Full Text] [Related]
11. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
[TBL] [Abstract][Full Text] [Related]
12. The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels.
Brickel N; Gandhi P; VanLandingham K; Hammond J; DeRossett S
Epilepsia; 2012 Apr; 53(4):606-12. PubMed ID: 22428574
[TBL] [Abstract][Full Text] [Related]
13. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ
PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937
[TBL] [Abstract][Full Text] [Related]
14. Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Wu JZ; Raszewski G; Czuczwar SJ
Naunyn Schmiedebergs Arch Pharmacol; 2009 Feb; 379(2):163-79. PubMed ID: 18773196
[TBL] [Abstract][Full Text] [Related]
15. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN
Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: a systematic review and indirect comparison.
Martyn-St James M; Glanville J; McCool R; Duffy S; Cooper J; Hugel P; Lane PW
Seizure; 2012 Nov; 21(9):665-78. PubMed ID: 22902288
[TBL] [Abstract][Full Text] [Related]
18. Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults.
Yamada M; Welty TE
Ann Pharmacother; 2012 Oct; 46(10):1358-67. PubMed ID: 22991134
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine extended-release as adjunctive therapy for partial seizures.
Naritoku DK; Warnock CR; Messenheimer JA; Borgohain R; Evers S; Guekht AB; Karlov VA; Lee BI; Pohl LR
Neurology; 2007 Oct; 69(16):1610-8. PubMed ID: 17938371
[TBL] [Abstract][Full Text] [Related]
20. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
